Literature DB >> 10909270

Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages.

H J Son, H J Lee, H S Yun-Choi, J H Ryu.   

Abstract

Nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha) are the major mediators produced in activated macrophages which contribute to the circulatory failure associated with septic shock. An activity-guided fractionation of an MeOH extract of stem bark of Magnolia obovata afforded two inhibitors of NO production in lipopolysaccharides (LPS)-activated macrophages by the suppression of i-NOS expression. Their structures were elucidated by spectroscopic methods to be magnolol and honokiol with IC50 values of 16.8 and 6.4 microM, respectively. They also inhibited the production of TNF-alpha in LPS-activated macrophages. Thus, these compounds may be possible candidates for the development of new drugs to treat endotoxemia accompanied by the overproduction of NO and TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909270     DOI: 10.1055/s-2000-8592

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  16 in total

1.  Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation.

Authors:  Te I Weng; Hsiao Yi Wu; Chia Wei Kuo; Shing Hwa Liu
Journal:  Intensive Care Med       Date:  2011-01-29       Impact factor: 17.440

2.  Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.

Authors:  S-N Wu; C-C Chen; H-F Li; Y-K Lo; S-A Chen; H-T Chiang
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.

Authors:  Shinichi Harada; Maya Kishimoto; Mana Kobayashi; Kazuo Nakamoto; Wakako Fujita-Hamabe; Hwei-Hsien Chen; Ming-Huan Chan; Shogo Tokuyama
Journal:  J Nat Med       Date:  2012-01-20       Impact factor: 2.343

4.  Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro.

Authors:  Chih-Kang Chiang; Meei-Ling Sheu; Yi-Wei Lin; Cheng-Tien Wu; Chin-Ching Yang; Min-Wei Chen; Kuan-Yu Hung; Kuan-Dun Wu; Shing-Hwa Liu
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

5.  Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma.

Authors:  Melissa E Munroe; Thomas R Businga; Joel N Kline; Gail A Bishop
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

6.  Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model.

Authors:  Wang Wei; Liang Dejie; Song Xiaojing; Wang Tiancheng; Cao Yongguo; Yang Zhengtao; Zhang Naisheng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

7.  Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediators.

Authors:  Tie-Cheng Yang; Shu-Wen Zhang; Li-Na Sun; Hong Wang; Ai-Min Ren
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

8.  Honokiol is a potent scavenger of superoxide and peroxyl radicals.

Authors:  Sergey Dikalov; Tanya Losik; Jack L Arbiser
Journal:  Biochem Pharmacol       Date:  2008-07-02       Impact factor: 5.858

9.  Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2012-07-31       Impact factor: 8.410

10.  Evaluation of oxygen radical absorbance capacity in kampo medicine.

Authors:  Ko Nishimura; Toshihiko Osawa; Kenji Watanabe
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.